BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25743457)

  • 1. Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm?
    Rajendra S
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):65-75. PubMed ID: 25743457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.
    Rubenstein JH; Thrift AP
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):41-50. PubMed ID: 25743455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
    Inadomi JM
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
    Barritt AS; Shaheen NJ
    Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's oesophagus: optimal strategies for prevention and treatment.
    Fass R; Sampliner RE
    Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and prevention of oesophageal adenocarcinoma.
    Ness-Jensen E
    Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Barrett esophagus. Current situation of the risk and surveillance policy].
    Robaszkiewicz M
    Presse Med; 1994 Dec; 23(40):1846-8. PubMed ID: 7899314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
    Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
    Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus exposure and sexual behavior are significant risk factors for Barrett's dysplasia/esophageal adenocarcinoma.
    Wong MYW; Wang B; Yang A; Khor A; Xuan W; Rajendra S
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29931323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of Barrett's oesophagus.
    Lim YC; Fitzgerald RC
    Br Med Bull; 2013; 107():117-32. PubMed ID: 23926313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.